Follow
Aldea Mihaela
Aldea Mihaela
Gustave Roussy, Villejuif, France
Verified email at gustaveroussy.fr
Title
Cited by
Cited by
Year
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
C Tomuleasa, O Soritau, A Orza, M Dudea, B Petrushev, O Mosteanu, ...
Journal of Gastrointestinal & Liver Diseases 21 (2), 2012
1152012
Overcoming resistance to tumor-targeted and immune-targeted therapies
M Aldea, F Andre, A Marabelle, S Dogan, F Barlesi, JC Soria
Cancer discovery 11 (4), 874-899, 2021
592021
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
M Aldea, L Craciun, C Tomuleasa, I Berindan-Neagoe, G Kacso, ...
Tumor Biology 35, 5101-5110, 2014
542014
Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells
MD Aldea, B Petrushev, O Soritau, CI Tomuleasa, I Berindan-Neagoe, ...
J buon 19 (2), 502-511, 2014
522014
Glioblastoma stem cells: a new target for metformin and arsenic trioxide.
M Carmignani, AR Volpe, M Aldea, O Soritau, A Irimie, IS Florian, ...
Journal of biological regulators and homeostatic agents 28 (1), 1-15, 2014
522014
Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression
M Aldea, L Hendriks, L Mezquita, C Jovelet, D Planchard, E Auclin, ...
Journal of Thoracic Oncology 15 (3), 383-391, 2020
512020
Tumour burden and efficacy of immune-checkpoint inhibitors
FG Dall’Olio, A Marabelle, C Caramella, C Garcia, M Aldea, N Chaput, ...
Nature Reviews Clinical Oncology 19 (2), 75-90, 2022
492022
Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas
O Soritau, C Tomuleasa, M Aldea, B Petrushev, S Susman, D Gheban, ...
J buon 16 (2), 282-289, 2011
472011
Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma
B Petrushev, C Tomuleasa, O Soritau, M Aldea, T Pop, S Susman, ...
Experimental Oncology, 2012
372012
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
M Aldea, E Orillard, L Mansi, A Marabelle, F Scotte, O Lambotte, ...
European Journal of Cancer 141, 239-251, 2020
352020
The role of depression and neuroimmune axis in the prognosis of cancer patients
M Aldea, L Craciun, C Tomuleasa, C Crivii
J BUON 19 (1), 5-14, 2014
352014
Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma
C Tomuleasa, O Soritau, E Fischer-Fodor, T Pop, S Susman, O Mosteanu, ...
Hematology/Oncology and Stem Cell Therapy 4 (2), 60-66, 2011
342011
Small cell lung cancer: a slightly less orphan disease after immunotherapy
J Remon, M Aldea, B Besse, D Planchard, M Reck, G Giaccone, JC Soria
Annals of Oncology 32 (6), 698-709, 2021
312021
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non–Small Cell Lung CancerctDNA …
S Ortiz-Cuaran, L Mezquita, A Swalduz, M Aldea, J Mazieres, C Leonce, ...
Clinical Cancer Research 26 (23), 6242-6253, 2020
252020
Metformin associated with photodynamic therapy–a novel oncological direction
I Nenu, T Popescu, MD Aldea, L Craciun, D Olteanu, C Tatomir, P Bolfa, ...
Journal of Photochemistry and Photobiology B: Biology 138, 80-91, 2014
242014
Overcoming resistance to tumor-targeted and immune-targeted therapies. Cancer Discov. 2021; 11: 874–899. doi: 10.1158/2159-8290
M Aldea, F Andre, A Marabelle, S Dogan, F Barlesi, JC Soria
CD-20-1638.[Abstract][CrossRef][Google Scholar], 0
20
Nanoparticles for targeting intratumoral hypoxia: exploiting a potential weakness of glioblastoma
M Aldea, IA Florian, G Kacso, L Craciun, S Boca, O Soritau, IS Florian
Pharmaceutical research 33, 2059-2077, 2016
182016
Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19Anticancer Drug Repurposing in COVID-19
M Aldea, JM Michot, FX Danlos, A Ribas, JC Soria
Cancer Discovery 11 (6), 1336-1344, 2021
122021
The effect of TSPP-mediated photodynamic therapy and Parecoxib in experimental tumours
T Popescu, I Nenu, MD Aldea, D Olteanu, D Gheban, C Tatomir, P Bolfa, ...
Life sciences 117 (2), 75-83, 2014
102014
Antidiabetic pharmacology: a link between metabolic syndrome and neuro-oncology
M Aldea, C Tomuleasa, B Petrushev, S Susman, GI Kacso, A Irimie, ...
J BUON 16 (3), 409-413, 2011
102011
The system can't perform the operation now. Try again later.
Articles 1–20